Human Vascular Tissue Models Formed from Human Induced Pluripotent Stem Cell Derived Endothelial Cells
Open accessThe DOI matches its Crossref record; 76 of the 78 references it cites were found in a registry or an index.
Abstract
Here we describe a strategy to model blood vessel development using a well-defined induced pluripotent stem cell-derived endothelial cell type (iPSC-EC) cultured within engineered platforms that mimic the 3D microenvironment. The iPSC-ECs used here were first characterized by expression of endothelial markers and functional properties that included VEGF responsiveness, TNF-α-induced upregulation of cell adhesion molecules (MCAM/CD146; ICAM1/CD54), thrombin-dependent barrier function, shear stress-induced alignment, and 2D and 3D capillary-like network formation in Matrigel. The iPSC-ECs also formed 3D vascular networks in a variety of engineering contexts, yielded perfusable, interconnected lumen when co-cultured with primary human fibroblasts, and aligned with flow in microfluidics devices. iPSC-EC function during tubule network formation, barrier formation, and sprouting was consistent with that of primary ECs, and the results suggest a VEGF-independent mechanism for sprouting, which is relevant to therapeutic anti-angiogenesis strategies. Our combined results demonstrate the feasibility of using a well-defined, stable source of iPSC-ECs to model blood vessel formation within a variety of contexts using standard in vitro formats.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Induction of Pluripotent Stem Cells from Adult Human Fibroblasts by Defined Factors
Takahashi, K., Tanabe, K., Ohnuki, M., Narita, M., Ichisaka, T., Tomoda, K., & Yamanaka, S. (2007) · Cell · doi:10.1016/j.cell.2007.11.019 · Cited by 20,221
Embryonic Stem Cell Lines Derived from Human Blastocysts
Thomson, J. A., Itskovitz-Eldor, J., Shapiro, S. S., Waknitz, M. A., Swiergiel, J. J., Marshall, V. S., & Jones, J. M. (1998) · Science · doi:10.1126/science.282.5391.1145 · Cited by 15,926 · cited 1×
“Human pluripotent stem cells have received increasing attention for tissue modeling applications, as they provide a well-defined source of tissue-specific cell types[16–18].”
Self-citationInduced Pluripotent Stem Cell Lines Derived from Human Somatic Cells
Yu, J., Vodyanik, M. A., Smuga-Otto, K., Antosiewicz-Bourget, J., Frane, J. L., Tian, S., Nie, J., Jonsdottir, G. A., Ruotti, V., Stewart, R., et al. (2007) · Science · doi:10.1126/science.1151526 · Cited by 10,310 · cited 1×
“Human pluripotent stem cells have received increasing attention for tissue modeling applications, as they provide a well-defined source of tissue-specific cell types[16–18].”
Self-citationMechanisms of angiogenesis and arteriogenesis
Carmeliet, P. (2000) · Nature Medicine · doi:10.1038/74651 · Cited by 4,162 · cited 11×
“These results are also consistent with previously reported roles for FGF2/FGFR signaling in promoting EC sprouting[50, 62, 69] and increasing vascular integrity independently of VEGF/VEGFR2 signaling[70].”
InfluentialFerrara, N., & Henzel, W. J. (1989) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(89)92678-8 · Cited by 2,268 · cited 1×
“1F), which is consistent with a role of VEGF/VEGFR2 signaling for promoting normal endothelial cell function[32, 33].”
Dimos, J. T., Rodolfa, K. T., Niakan, K. K., Weisenthal, L. M., Mitsumoto, H., Chung, W., Croft, G. F., Saphier, G., Leibel, R., Goland, R., et al. (2008) · Science · doi:10.1126/science.1158799 · Cited by 1,962 · cited 1×
“Induced pluripotent stem cells (iPSC) are a particularly promising cell source for modeling tissue development and pathologies associated with specific genetic defects, since patientderived tissues can be generated using both disease-relevant cell lines and control cell lines[19–22].”
Millauer, B., Wizigmann-Voos, S., Schnürch, H., Martinez, R., Møller, N. P. H., Risau, W., & Ullrich, A. (1993) · Cell · doi:10.1016/0092-8674(93)90573-9 · Cited by 1,927 · cited 1×
“1f), which is consistent with a role of VEGF/VEGFR2 signaling for promoting normal endothelial cell function [32, 33].”
Signaling Mechanisms Regulating Endothelial Permeability
Mehta, D., & Malik, A. B. (2006) · Physiological Reviews · doi:10.1152/physrev.00012.2005 · Cited by 1,720 · cited 2×
“Endothelial cells change their barrier properties during wound healing and inflammation[34] and differentially express the adhesion molecules intercellular adhesion molecule (ICAM) and melanoma cell adhesion molecule (MCAM) to recruit circulating immune and progenitor cells[35].”
VEGF-targeted therapy: mechanisms of anti-tumour activity
Ellis, L. M., & Hicklin, D. J. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2403 · Cited by 1,673 · cited 1×
“VEGF inhibition decreases EC single cell migration and may promote sprouting, which could have important implications related to the confounding results of anti-VEGF therapy to reduce tumor growth[71].”
Induced pluripotent stem cells from a spinal muscular atrophy patient
Ebert, A. D., Yu, J., Rose, F. F., Mattis, V. B., Lorson, C. L., Thomson, J. A., & Svendsen, C. N. (2009) · Nature · doi:10.1038/nature07677 · Cited by 1,441 · cited 1×
“Induced pluripotent stem cells (iPSC) are a particularly promising cell source for modeling tissue development and pathologies associated with specific genetic defects, since patientderived tissues can be generated using both disease-relevant cell lines and control cell lines[19–22].”
Self-citationVoyta, J. C., Via, D. P., Butterfield, C. E., & Zetter, B. R. (1984) · The Journal of cell biology · doi:10.1083/jcb.99.6.2034 · Cited by 1,239 · cited 1×
“1A)[29], stained positive for UEA-1 (Fig.”
Kubota, Y., Kleinman, H. K., Martin, G. R., & Lawley, T. J. (1988) · The Journal of cell biology · doi:10.1083/jcb.107.4.1589 · Cited by 1,209 · cited 1×
“3C)[43, 44], with similar results observed for HUVECs (Fig.”
The Dynamic Response of Vascular Endothelial Cells to Fluid Shear Stress
Dewey, C. F., Bussolari, S. R., Gimbrone, M. A., & Davies, P. F. (1981) · Journal of Biomechanical Engineering · doi:10.1115/1.3138276 · Cited by 1,136 · cited 3×
“4C) during static culture in a perfusable bioreactor[47], consistent with a possible role for shear stress in directing cytoskeletal organization[48].”
Vascularization is the key challenge in tissue engineering
Novosel, E. C., Kleinhans, C., & Kluger, P. J. (2011) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2011.03.004 · Cited by 1,062 · cited 1×
“The lack of a functional vasculature in healing or transplanted tissues has motivated efforts to deconstruct the critical factors that stimulate blood vessel maintenance and growth[1, 2].”
Molecular control of endothelial cell behaviour during blood vessel morphogenesis
Herbert, S. P., & Stainier, D. Y. R. (2011) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3176 · Cited by 1,042 · cited 1×
“These studies highlight the importance of context for drug screening applications, as growth factor signaling[61, 73, 74] and the cellular cytoskeleton[54] exhibit different effects on EC function (i.”
Folkman, J., & Haudenschild, C. (1980) · Nature · doi:10.1038/288551a0 · Cited by 1,037 · cited 1×
“iPSC-ECs Align in Response to Shear Stress and Form Capillary-Like Networks with Perfusable Lumen A hallmark for endothelial cell function is the capacity to form capillarylike networks in 2D and 3D contexts [3–5, 23, 41–46].”
Three-dimensional microfluidic model for tumor cell intravasation and endothelial barrier function
Zervantonakis, I. K., Hughes-Alford, S. K., Charest, J. L., Condeelis, J. S., Gertler, F. B., & Kamm, R. D. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1210182109 · Cited by 872
Self-citationEngineering of functional, perfusable 3D microvascular networks on a chip
Kim, S., Lee, H., Chung, M., & Jeon, N. L. (2013) · Lab on a Chip · doi:10.1039/c3lc41320a · Cited by 872
SU11248 is a novel FLT3 tyrosine kinase inhibitor with potent activity in vitro and in vivo
O'Farrell, A.-M., Abrams, T. J., Yuen, H. A., Ngai, T. J., Louie, S. G., Yee, K. W. H., Wong, L. M., Hong, W., Lee, L. B., Town, A., et al. (2003) · Blood · doi:10.1182/blood-2002-07-2307 · Cited by 864 · cited 1×
“Known pharmacological protein kinase inhibitors that have been previously investigated as therapeutic antiangiogenic agents disrupted iPSC-EC sprouting in our experiments, including inhibitors of MEK (PD0325901 [63]), protein kinases (Staurosporine[64]), histone deacetylases (Trichostatin A[65]), and receptor tyrosine…”
Endothelial cells derived from human embryonic stem cells
Levenberg, S., Golub, J. S., Amit, M., Itskovitz-Eldor, J., & Langer, R. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.032074999 · Cited by 817
Endothelial cell diversity revealed by global expression profiling
Chi, J.-T., Chang, H. Y., Haraldsen, G., Jahnsen, F. L., Troyanskaya, O. G., Chang, D. S., Wang, Z., Rockson, S. G., van de Rijn, M., Botstein, D., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1434429100 · Cited by 771 · cited 1×
“specific heterogeneity[11, 59] and present challenges for robust design of in vitro”
Grant, D. S., Tashiro, K.-I., Segui-Real, B., Yamada, Y., Martin, G. R., & Kleinman, H. K. (1989) · Cell · doi:10.1016/0092-8674(89)90945-8 · Cited by 740 · cited 1×
“3C)[43, 44], with similar results observed for HUVECs (Fig.”
Montesano, R., Orci, L., & Vassalli, P. (1983) · The Journal of cell biology · doi:10.1083/jcb.97.5.1648 · Cited by 647 · cited 1×
“iPSC-ECs Align in Response to Shear Stress and Form Capillary-Like Networks with Perfusable Lumen A hallmark for endothelial cell function is the capacity to form capillarylike networks in 2D and 3D contexts [3–5, 23, 41–46].”
Improving the Human Hazard Characterization of Chemicals: A Tox21 Update
Tice, R. R., Austin, C. P., Kavlock, R. J., & Bucher, J. R. (2013) · Environmental Health Perspectives · doi:10.1289/ehp.1205784 · Cited by 618
SIRT1 Controls Endothelial Angiogenic Functions During Vascular Growth
Potente, M., Ghaeni, L., Baldessari, D., Mostoslavsky, R., Rossig, L., Dequiedt, F., Haendeler, J., Mione, M., Dejana, E., Alt, F. W., et al. (2007) · Genes & Development · doi:10.1101/gad.435107 · Cited by 608 · cited 1×
“Endothelial cell sprouting comprises the initial stage of angiogenesis, and assays for EC sprouting[49–52] represent valuable tools for the screening and development of angiogenesis regulators[53].”
Nolan, D. J., Ginsberg, M., Israely, E., Palikuqi, B., Poulos, M. G., James, D., Ding, B.-S., Schachterle, W., Liu, Y., Rosenwaks, Z., et al. (2013) · Developmental Cell · doi:10.1016/j.devcel.2013.06.017 · Cited by 603 · cited 2×
“However, the complexity of blood vessel specification and heterogeneity of primary human endothelial cells[11] limits the robustness of engineered vascular models.”
Formation of perfused, functional microvascular tubes in vitro
Chrobak, K. M., Potter, D. R., & Tien, J. (2006) · Microvascular Research · doi:10.1016/j.mvr.2006.02.005 · Cited by 553 · cited 1×
“Hydrogels with defined extracellular matrix (ECM) properties[3–5] and microfluidics approaches for controlling soluble gradients, flow, and surface shear[6, 7] have been used to model vasculature in 3-dimensional (3D) microenvironments[8–10].”
Hematopoietic and Endothelial Differentiation of Human Induced Pluripotent Stem Cells
Choi, K.-D., Yu, J., Smuga-Otto, K., Salvagiotto, G., Rehrauer, W. M., Vodyanik, M. A., Thomson, J. L., & Slukvin, I. I. (2009) · Stem Cells · doi:10.1002/stem.20080922 · Cited by 492 · cited 3×
“Human pluripotent stem cells provide unique advantages for deriving tissue-specific cell types, and numerous protocols exist to differentiate stem cells into ECs[23–28].”
Self-citationA critical analysis of current in vitro and in vivo angiogenesis assays
Staton, C. A., Reed, M. W. R., & Brown, N. J. (2009) · International Journal of Experimental Pathology · doi:10.1111/j.1365-2613.2008.00633.x · Cited by 469 · cited 1×
“derived from patients and expanded in vitro[58].”
Tensional forces in fibrillar extracellular matrices control directional capillary sprouting
Korff, T., & Augustin, H. G. (1999) · Journal of Cell Science · doi:10.1242/jcs.112.19.3249 · Cited by 450
Nakatsu, M. N., Sainson, R. C. A., Aoto, J. N., Taylor, K. L., Aitkenhead, M., Pérez-del-Pulgar, S., Carpenter, P. M., & Hughes, C. C. W. (2003) · Microvascular Research · doi:10.1016/s0026-2862(03)00045-1 · Cited by 449 · cited 1×
“7A), consistent with VEGF-dependent sprouting of primary endothelial cells[50, 55].”
Perfused multiwell plate for 3D liver tissue engineering
Domansky, K., Inman, W., Serdy, J., Dash, A., Lim, M. H. M., & Griffith, L. G. (2010) · Lab Chip · doi:10.1039/b913221j · Cited by 444 · cited 1×
“4C) during static culture in a perfusable bioreactor[47], consistent with a possible role for shear stress in directing cytoskeletal organization[48].”
Self-citationIn Vitro Perfused Human Capillary Networks
Moya, M. L., Hsu, Y.-H., Lee, A. P., Hughes, C. C. W., & George, S. C. (2013) · Tissue Engineering Part C: Methods · doi:10.1089/ten.tec.2012.0430 · Cited by 387 · cited 1×
“Hydrogels with defined extracellular matrix (ECM) properties[3–5] and microfluidics approaches for controlling soluble gradients, flow, and surface shear[6, 7] have been used to model vasculature in 3-dimensional (3D) microenvironments[8–10].”
Wang, L., Li, L., Shojaei, F., Levac, K., Cerdan, C., Menendez, P., Martin, T., Rouleau, A., & Bhatia, M. (2004) · Immunity · doi:10.1016/j.immuni.2004.06.006 · Cited by 374
Biomimetic hydrogels with pro-angiogenic properties
Moon, J. J., Saik, J. E., Poché, R. A., Leslie-Barbick, J. E., Lee, S.-H., Smith, A. A., Dickinson, M. E., & West, J. L. (2010) · Biomaterials · doi:10.1016/j.biomaterials.2010.01.104 · Cited by 364
Vickerman, V., Blundo, J., Chung, S., & Kamm, R. (2008) · Lab on a Chip · doi:10.1039/b802395f · Cited by 340 · cited 1×
“Hydrogels with defined extracellular matrix (ECM) properties[3–5] and microfluidics approaches for controlling soluble gradients, flow, and surface shear[6, 7] have been used to model vasculature in 3-dimensional (3D) microenvironments[8–10].”
Self-citationMavria, G., Vercoulen, Y., Yeo, M., Paterson, H., Karasarides, M., Marais, R., Bird, D., & Marshall, C. J. (2006) · Cancer Cell · doi:10.1016/j.ccr.2005.12.021 · Cited by 335 · cited 2×
“Known pharmacological protein kinase inhibitors that have been previously investigated as therapeutic antiangiogenic agents disrupted iPSC-EC sprouting in our experiments, including inhibitors of MEK (PD0325901 [63]), protein kinases (Staurosporine[64]), histone deacetylases (Trichostatin A[65]), and receptor tyrosine…”
“Sprouting angiogenesis”, a reappraisal
Ribatti, D., & Crivellato, E. (2012) · Developmental Biology · doi:10.1016/j.ydbio.2012.09.018 · Cited by 325 · cited 1×
“Endothelial cell sprouting comprises the initial stage of angiogenesis, and assays for EC sprouting [49–52] represent A B”
Flk-1 as a target for tumor growth inhibition.
Strawn, L. M., McMahon, G., App, H., Schreck, R., Kuchler, W. R., Longhi, M. P., Hui, T. H., Tang, C., Levitzki, A., Gazit, A., et al. (1996) · PubMed · Cited by 316
The FGF system has a key role in regulating vascular integrity
Murakami, M., Nguyen, L. T., Zhang, Z. W., Moodie, K. L., Carmeliet, P., Stan, R. V., & Simons, M. (2008) · Journal of Clinical Investigation · doi:10.1172/jci35298 · Cited by 303 · cited 1×
“These results are also consistent with previously reported roles for FGF2/FGFR signaling in promoting EC sprouting[50, 62, 69] and increasing vascular integrity independently of VEGF/VEGFR2 signaling[70].”
Bioartificial matrices for therapeutic vascularization
Phelps, E. A., Landázuri, N., Thulé, P. M., Taylor, W. R., & García, A. J. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0905447107 · Cited by 274 · cited 2×
“Hydrogels with defined extracellular matrix (ECM) properties[3–5] and microfluidics approaches for controlling soluble gradients, flow, and surface shear[6, 7] have been used to model vasculature in 3-dimensional (3D) microenvironments[8–10].”
Hu, K., Yu, J., Suknuntha, K., Tian, S., Montgomery, K., Choi, K.-D., Stewart, R., Thomson, J. A., & Slukvin, I. I. (2011) · Blood · doi:10.1182/blood-2010-07-298331 · Cited by 254 · cited 1×
“Induced pluripotent stem cells (iPSC) are a particularly promising cell source for modeling tissue development and pathologies associated with specific genetic defects, since patientderived tissues can be generated using both disease-relevant cell lines and control cell lines[19–22].”
Self-citationYoshida, A., Anand-apte, B., & Zetter, B. R. (1996) · Growth Factors · doi:10.3109/08977199609034566 · Cited by 252 · cited 1×
“These studies highlight the importance of context for drug screening applications, as growth factor signaling[61, 73, 74] and the cellular cytoskeleton[54] exhibit different effects on EC function (i.”
Control of Perfusable Microvascular Network Morphology Using a Multiculture Microfluidic System
Whisler, J. A., Chen, M. B., & Kamm, R. D. (2014) · Tissue Engineering Part C: Methods · doi:10.1089/ten.tec.2013.0370 · Cited by 242 · cited 1×
“Microfluidic Experiments The procedure for forming perfusable microvascular networks in a multi-culture microfluidic system is described in detail elsewhere [75].”
Self-citationSelf-organized vascular networks from human pluripotent stem cells in a synthetic matrix
Kusuma, S., Shen, Y.-I., Hanjaya-Putra, D., Mali, P., Cheng, L., & Gerecht, S. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1306562110 · Cited by 225
Jackson, C. J., Garbett, P. K., Nissen, B., & Schrieber, L. (1990) · Journal of Cell Science · doi:10.1242/jcs.96.2.257 · Cited by 211
Engineering more than a cell: vascularization strategies in tissue engineering
Phelps, E. A., & García, A. J. (2010) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2010.06.005 · Cited by 174 · cited 1×
“The lack of a functional vasculature in healing or transplanted tissues has motivated efforts to deconstruct the critical factors that stimulate blood vessel maintenance and growth[1, 2].”
Leslie-Barbick, J. E., Saik, J. E., Gould, D. J., Dickinson, M. E., & West, J. L. (2011) · Biomaterials · doi:10.1016/j.biomaterials.2011.04.060 · Cited by 174
Leslie-Barbick, J. E., Moon, J. J., & West, J. L. (2009) · Journal of Biomaterials Science, Polymer Edition · doi:10.1163/156856208x386381 · Cited by 171 · cited 1×
“A hallmark for endothelial cell function is the capacity to form capillary-like networks in 2D and 3D contexts[3–5, 23, 41–46].”
Thrombin-induced gap formation in confluent endothelial cell monolayers in vitro
Laposata, M., Dovnarsky, D., & Shin, H. (1983) · Blood · doi:10.1182/blood.v62.3.549.549 · Cited by 166 · cited 1×
“Thus, iPSC-ECs exhibited reversible changes in barrier function consistent with previous studies of EC monolayers treated with edemagenic agents (including thrombin) at low concentrations[38, 39].”
Barkefors, I., Le Jan, S., Jakobsson, L., Hejll, E., Carlson, G., Johansson, H., Jarvius, J., Park, J. W., Li Jeon, N., & Kreuger, J. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m704917200 · Cited by 163 · cited 1×
“We hypothesized that the mechanism for VEGF-induced sprouting involved increased migration of iPSC-ECs, which is consistent with the role of VEGF for inducing endothelial cell chemotaxis[56, 57].”
Chung, S., Sudo, R., Vickerman, V., Zervantonakis, I. K., & Kamm, R. D. (2010) · Annals of Biomedical Engineering · doi:10.1007/s10439-010-9899-3 · Cited by 154 · cited 1×
“Hydrogels with defined extracellular matrix (ECM) properties[3–5] and microfluidics approaches for controlling soluble gradients, flow, and surface shear[6, 7] have been used to model vasculature in 3-dimensional (3D) microenvironments[8–10].”
Self-citationCD146 and its Soluble Form Regulate Monocyte Transendothelial Migration
Bardin, N., Blot‐Chabaud, M., Despoix, N., Kebir, A., Harhouri, K., Arsanto, J., Espinosa, L., Perrin, P., Robert, S., Vely, F., et al. (2009) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.108.183251 · Cited by 150 · cited 3×
“Endothelial cells change their barrier properties during wound healing and inflammation[34] and differentially express the adhesion molecules intercellular adhesion molecule (ICAM) and melanoma cell adhesion molecule (MCAM) to recruit circulating immune and progenitor cells[35].”
Genetic correction and analysis of induced pluripotent stem cells from a patient with gyrate atrophy
Howden, S. E., Gore, A., Li, Z., Fung, H.-L., Nisler, B. S., Nie, J., Chen, G., McIntosh, B. E., Gulbranson, D. R., Diol, N. R., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1103388108 · Cited by 148 · cited 1×
“Induced pluripotent stem cells (iPSC) are a particularly promising cell source for modeling tissue development and pathologies associated with specific genetic defects, since patientderived tissues can be generated using both disease-relevant cell lines and control cell lines[19–22].”
Self-citationHuman induced pluripotent stem cell-derived endothelial cells exhibit functional heterogeneity.
Rufaihah, A. J., Huang, N. F., Kim, J., Herold, J., Volz, K. S., Park, T. S., Lee, J. C., Zambidis, E. T., Pera, R. A. R., & Cooke, J. P. (2013) · Europe PMC (PubMed Central) · Cited by 146
Wetmore, B. A., Wambaugh, J. F., Ferguson, S., Li, L., M.A., H. J. C. I., Judson, R., Freeman, K., Bao, W., Sochaski, M. A., Chu, T., et al. (2013) · Toxicological Sciences · doi:10.1093/toxsci/kft012 · Cited by 137 · cited 2×
“Robust models of vasculature are likely required for emerging tissue modeling applications that rely on standardization and quantitative readouts to enable toxicity and drug screening[12–15].”
Environmental Impact on Vascular Development Predicted by High-Throughput Screening
Kleinstreuer, N. C., Judson, R. S., Reif, D. M., Sipes, N. S., Singh, A. V., Chandler, K. J., DeWoskin, R., Dix, D. J., Kavlock, R. J., & Knudsen, T. B. (2011) · Environmental Health Perspectives · doi:10.1289/ehp.1103412 · Cited by 133 · cited 2×
“Robust models of vasculature are likely required for emerging tissue modeling applications that rely on standardization and quantitative readouts to enable toxicity and drug screening[12–15].”
Sun, L., Tran, N., Liang, C., Hubbard, S. R., Tang, F. L. M., Lipson, K. E., Schreck, R., Zhou, Y. G., McMahon, G., & Tang, C. (2000) · Journal of Medicinal Chemistry · doi:10.1021/jm9906116 · Cited by 113 · cited 12×
“Image series demonstrates sprouting in the presence of growth medium (C.i) with SU5402 (ii), nocodazole (iii.)”
InfluentialWhite, M. P., Rufaihah, A. J., Liu, L., Ghebremariam, Y. T., Ivey, K. N., Cooke, J. P., & Srivastava, D. (2013) · Stem Cells · doi:10.1002/stem.1267 · Cited by 106 · cited 2×
“Multiple strategies for human endothelial cell (EC) differentiation have been reported for both embryonic stem cells and induced pluripotent stem cells[23–28].”
Kane, N. M., Xiao, Q., Baker, A. H., Luo, Z., Xu, Q., & Emanueli, C. (2011) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2010.10.004 · Cited by 90 · cited 2×
“Multiple strategies for human endothelial cell (EC) differentiation have been reported for both embryonic stem cells and induced pluripotent stem cells[23–28].”
Liu, T., Castelo‐Branco, P., Rabkin, S. D., & Martuza, R. L. (2008) · Molecular Therapy · doi:10.1038/mt.2008.58 · Cited by 76 · cited 1×
“Known pharmacological protein kinase inhibitors that have been previously investigated as therapeutic antiangiogenic agents disrupted iPSC-EC sprouting in our experiments, including inhibitors of MEK (PD0325901 [63]), protein kinases (Staurosporine[64]), histone deacetylases (Trichostatin A[65]), and receptor tyrosine…”
Nguyen, E. H., Zanotelli, M. R., Schwartz, M. P., & Murphy, W. L. (2013) · Biomaterials · doi:10.1016/j.biomaterials.2013.11.054 · Cited by 75
Self-citationDevelopment of targeted angiogenic medicine
Loges, S., Roncal, C., & Carmeliet, P. (2008) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2008.03203.x · Cited by 67 · cited 1×
“Endothelial cell sprouting comprises the initial stage of angiogenesis, and assays for EC sprouting[49–52] represent valuable tools for the screening and development of angiogenesis regulators[53].”
Mabeta, P., & Pepper, M. S. (2009) · Angiogenesis · doi:10.1007/s10456-009-9134-8 · Cited by 61
van Horssen, R., Galjart, N., Rens, J. A. P., Eggermont, A. M. M., & ten Hagen, T. L. M. (2006) · Journal of Cellular Biochemistry · doi:10.1002/jcb.20994 · Cited by 60 · cited 1×
“We hypothesized that the mechanism for VEGF-induced sprouting involved increased migration of iPSC-ECs, which is consistent with the role of VEGF for inducing endothelial cell chemotaxis[56, 57].”
Spiekermann, K., Faber, F., Voswinckel, R., & Hiddemann, W. (2002) · Experimental Hematology · doi:10.1016/s0301-472x(02)00837-8 · Cited by 58 · cited 1×
“6E), which confirms a role of VEGF/VEGFR2 for inducing sprouting[50, 67].”
Inhibition of angiogenesis by staurosporine, a potent protein kinase inhibitor.
Oikawa, T., Shimamura, M., ASHING, H., Nakamura, O., Kanayasu, T., Morita, I., & Murota, S. (1992) · The Journal of Antibiotics · doi:10.7164/antibiotics.45.1155 · Cited by 56 · cited 1×
“Known pharmacological protein kinase inhibitors that have been previously investigated as therapeutic antiangiogenic agents disrupted iPSC-EC sprouting in our experiments, including inhibitors of MEK (PD0325901 [63]), protein kinases (Staurosporine[64]), histone deacetylases (Trichostatin A[65]), and receptor tyrosine…”
Woad, K. J., Hunter, M. G., Mann, G. E., Laird, M., Hammond, A. J., & Robinson, R. S. (2011) · Reproduction · doi:10.1530/rep-11-0277 · Cited by 53 · cited 4×
“The observed inhibition of VEGF-dependent iPSC-EC sprouting at 1 μM SU5402 is consistent with previously measured SU5402 inhibition of VEGF- and FGF2-dependent tubule network formation for primary ECs[62, 72].”
InfluentialFGF2 is crucial for the development of bovine luteal endothelial networks in vitro
Woad, K. J., Hammond, A. J., Hunter, M. G., Mann, G. E., Hunter, M. G., & Robinson, R. S. (2009) · Reproduction · doi:10.1530/rep-09-0030 · Cited by 53 · cited 1×
“The observed inhibition of VEGF-dependent iPSC-EC sprouting at 1 μM SU5402 is consistent with previously measured SU5402 inhibition of VEGF- and FGF2-dependent tubule network formation for primary ECs[62, 72].”
Moy, A. B., Blackwell, K., & Kamath, A. M. (2002) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.2002.282.1.h21 · Cited by 51 · cited 1×
“Thus, iPSC-ECs exhibited reversible changes in barrier function consistent with previous studies of EC monolayers treated with edemagenic agents (including thrombin) at low concentrations[38, 39].”
Krause, D., Mischeck, U., Galla, H., & Dermietzel, R. (1991) · Neuroscience Letters · doi:10.1016/0304-3940(91)90284-z · Cited by 49 · cited 1×
“2A) provided evidence of tight junction formation[36, 37].”
Gardner, T. W., Eller, A. W., Friberg, T. R., DʼAntonio, J. A., & Hollis, T. M. (1995) · Retina · doi:10.1097/00006982-199515020-00008 · Cited by 40
Haspel, H. C., Scicli, G. M., McMahon, G., & Scicli, A. G. (2002) · Microvascular Research · doi:10.1006/mvre.2001.2383 · Cited by 39 · cited 3×
“6E), which confirms a role of VEGF/VEGFR2 for inducing sprouting[50, 67].”
Piossek, C., Thierauch, K., Schneider‐Mergener, J., Volkmer, R., Bachmann, M. F., Korff, T., Augustin, H. G., & Germeroth, L. (2003) · Thrombosis and Haemostasis · doi:10.1160/th03-02-0106 · Cited by 23
Incorporating Biological, Chemical, and Toxicological Knowledge Into Predictive Models of Toxicity
Dix, D. J., Houck, K. A., Judson, R., Kleinstreuer, N., Knudsen, T. B., Martin, M. T., Reif, D. M., Richard, A. M., Shah, I., Sipes, N. S., et al. (2012) · Toxicological Sciences · doi:10.1093/toxsci/kfs281 · Cited by 21 · cited 2×
“Robust models of vasculature are likely required for emerging tissue modeling applications that rely on standardization and quantitative readouts to enable toxicity and drug screening[12–15].”
Thrombin-induced gap formation in confluent endothelial cell monolayers in vitro
Laposata, M., Dovnarsky, D., & Shin, H. (1983) · Blood · doi:10.1182/blood.v62.3.549.bloodjournal623549
Cited by
Campisi, M., Shin, Y., Osaki, T., Hajal, C., Chiono, V., & Kamm, R. D. (2018) · Biomaterials · doi:10.1016/j.biomaterials.2018.07.014 · Cited by 718
“iPSC-ECs were selected as they are immature endothelial cells, capable of organizing into a complex and perfusable vascular network [41], with lower permeability values compared to other non-brain EC models [42e44].”
MethodSelf-citationVascular Tissue Engineering: Progress, Challenges, and Clinical Promise
Song, H.-H. G., Rumma, R. T., Ozaki, C. K., Edelman, E. R., & Chen, C. S. (2018) · Cell Stem Cell · doi:10.1016/j.stem.2018.02.009 · Cited by 476
“used commercially available hiPSC-derived ECs in their microfluidics device to demonstrate that these cells can form not only interconnected, but also perfusable vascular networks in vitro when cocultured with primary human lung fibroblasts (Belair et al., 2015).”
MethodVascularized organoids on a chip: strategies for engineering organoids with functional vasculature
Zhang, S., Wan, Z., & Kamm, R. D. (2021) · Lab on a Chip · doi:10.1039/d0lc01186j · Cited by 316
Self-citationRadke, D., Jia, W., Sharma, D., Fena, K., Wang, G., Goldman, J., & Zhao, F. (2018) · Advanced Healthcare Materials · doi:10.1002/adhm.201701461 · Cited by 256
Control of Perfusable Microvascular Network Morphology Using a Multiculture Microfluidic System
Whisler, J. A., Chen, M. B., & Kamm, R. D. (2014) · Tissue Engineering Part C: Methods · doi:10.1089/ten.tec.2013.0370 · Cited by 242
Self-citation
Metadata
- Authors
- Belair, D. G., Whisler, J. A., Valdez, J., Velazquez, J., Molenda, J. A., Vickerman, V., Lewis, R., Daigh, C., Hansen, T. D., Mann, D. A., Thomson, J. A., Griffith, L. G., Kamm, R. D., Schwartz, M. P., & Murphy, W. L.
- Affiliations
- University of Wisconsin–Madison (US)
- Massachusetts Institute of Technology (US)
- Morgridge Institute for Research (US)
- Cellular Dynamics International (United States) (US)
- Corresponding author
- Murphy, William L.
- ORCID
- Venue
- Stem Cell Reviews and Reports
- Published
- 2014-09-05
- Volume
- 11
- Issue
- 3
- Pages
- 511-525
- ISSN
- 1550-8943 (ISSN-L)
- 1558-6804
- PMC
- PMC4411213
- OpenAlex
- W1977611420
- Semantic Scholar
- 003eda2297553e2dfd37af8afb48a613b894b945
- Cited by
- 120
- References
- 78
- Citations by year
- 2026: 1 · 2025: 6 · 2024: 7 · 2023: 5 · 2022: 12 · 2021: 16 · 2020: 11 · 2019: 13 · 2018: 15 · 2017: 17 · 2016: 8 · 2015: 7 · 2014: 1
- FWCI
- 4.51
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Stem Cell Reviews and Reports (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- DSpace@MIT (Massachusetts Institute of Technology) (submittedVersion, cc-by-nc-sa)
- PMC
- Funders
- National Institutes of Health (UH3TR000506, UH2TR000506)
- National Heart, Lung, and Blood Institute (R01HL093282, T32HL007936)
- National Institute of Biomedical Imaging and Bioengineering (R21EB016381)
- National Center for Advancing Translational Sciences
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Angiogenesis and VEGF in Cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Pluripotent Stem Cells Research
- Physical Sciences › Engineering › Biomedical Engineering › 3D Printing in Biomedical Research
- Keywords
- induced pluripotent stem cell-derived endothelial cells, vascular tissue engineering, blood vessel development, capillary network formation, endothelial barrier function, sprouting angiogenesis, angiogenesis inhibition, microfluidics, adhesion molecules
- MeSH terms
- Blood Vessels, Cell Differentiation, Fibroblasts, Humans, Tumor Necrosis Factor-alpha, Gene Expression Regulation, Developmental, Neovascularization, Physiologic, Vascular Endothelial Growth Factor A, Endothelial Cells, Induced Pluripotent Stem Cells
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.